23/07/2025
We’re delighted to have helped Aptamer Group, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, with a £2m equity fundraising by way of a Placing.
The proposed Placing will enable the Company to accelerate the commercialisation of its Optimer® technology, further develop its intellectual property portfolio, and advance its licensing pipeline. The additional capital will support ongoing research and development, expand fee-for-service capabilities, and strengthen the Company's position as a leader in the global aptamer market, driving long-term value creation for shareholders.
Dr Adam Hargreaves, Non-Executive Chairman and Dr Arron Tolley, Chief Executive Officer of Aptamer Group, commented: "With a lean cost base and robust pipeline, the Board believes the Company is poised to convert collaborations into revenue and lead globally. We would like to thank our existing and incoming shareholders for their support."
Our thanks to our wonderful clients at the company, nominated advisor SPARK and legal advisor Squire Patton Boggs.
If you'd like to find out how we can help ensure the success of your equity fundraisings, chat with us today: hello@blackandcallow.com
